Gerard Evan

Gerard Ian Evan FRS, FMedSci (born 17 August 1955) is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor of Biochemistry and Head of Biochemistry at the University of Cambridge (2009-2022).^[11][13]

Gerard Evan
Born	(1955-08-17) 17 August 1955 (age 70)[1]
Alma mater	St Peter's College, Oxford King's College, Cambridge[1]
Known for	Disease Models & Mechanisms
Awards	Fellow of the Royal Society (2004) FMedSci (1999)[2] PhD (1982)
Scientific career
Fields	Cancer[3][4][5][6][7][8] Disease biology Myc regulator gene[9] p53 tumour suppressor[10]
Institutions	University of Oxford University of Cambridge UCSF[1][11] Cancer Research UK[12] Ensemble Therapeutics
Thesis	Monoclonal antibodies as reagents for the analysis of cell surfaces (1982)
Website	www.bioc.cam.ac.uk/uto/evan labmed.ucsf.edu/about/faculty/pathology-gevan.html

Education

Evan was educated at St Peter's College, Oxford, where he studied Biochemistry, and King's College, Cambridge, where he was awarded his PhD in 1982 for research using Monoclonal antibodies.^[1][14]

Research

Evan does research to the determine the molecular basis of cancer.^{[15][16][17][18][19][20][21][22]}

Career

Prior to Cambridge, Evan was Royal Society Napier Professor at University College London and the Imperial Cancer Research Fund (1988-99), then Gerson & Barbara Bass Bakar Distinguished Professor of Cancer Biology, at University of California, San Francisco (1999-2011).